On Wednesday of this week, the eighth annual Diabetes Technology Meeting convenes in Bethesda, MD, for a three-day event (spanning this year's World Diabetes Day on Thursday) that will survey the latest technological advances for people with diabetes.  How I'd love to be a fly on the wall at that conference!

Nevermind that I've been trying to gain press access to this meeting for at least the last 3 years; I have a mole this year, who's promised to report back directly, especially if someone as influential as the ADA's Richard Kahn gets up again and raises eyebrows by making an anti-diabetes-technology speech right there among the country's leading D-tech experts.

That probably won't happen again.  But reviewing the agenda (also published here on DiabetesMine, below this post) reveals that there will still be a lot of discussion about the relative value of glucose monitoring in Type 2 diabetics (sheesh!)  Since this stuff is so crucial to our lives with diabetes, allow me to walk you through some agenda highlights:

You can see that early in on Day 1, there's a two-part, 3.5-hour panel on non-invasive glucose monitoring (the dream is not dead!) including new technology for measuring glucose in tears ( Sandy Asher, University of Pittsburgh).

Mid-afternoon will feature a workshop on new ways to measure the effects of diet and exercise on glucose control, using — you guessed it!—  continuous glucose monitoring (aka CGM systems). Proof points for our fight for insurance coverage of this technology, I wonder?

This is followed by another lengthy two-part workshop (divided into academic and industry perspectives) on Self-Monitoring of Blood Glucose (SMBG) in Type 2 patients. A representative from the FDA will be speaking on "Challenges for Decision-Making Software" (?) and another from Roche Germany will be presenting "The Value Chain of SMBG" (?)  Coming from Roche it must be pro-meter use, I figure.  At 5pm, a guy from Microsoft Health Solutions Group will be discussing "Bringing Diabetes Care into the Internet Age."  Those are the slides I'm after!

On Day 2, Aaron Kowalski, strategic research director of the JDRF will be giving a keynote address on Accelerating the Availability of the Artificial Pancreas. Wow. I've pinged him to try to get some details on the "A" word there (acceleration).

Later they'll be an in-depth session on applying nanotechnology to diabetes care — manipulating matter at the atomic and molecular scale.  The companies iSense and Diasome will be presenting their unique approaches. (More on the latter here soon.)

And on Day 3, Saturday, the experts will discuss the latest in insulin delivery technology and tissue engineering for insulin production, including a Novocell presentation on the "Bioartificial Pancreas." For details, see this reference from 2002: "Slow Progress, But Much Promise."  Yeah, we know.

After lunch, there'll be a session on "Techonologies for Improving Adherance," including video games and an "Online Accelerometer" for weight loss and fitness from the Diabetes Prevention Source in Los Angeles. (Note: I'd like to have an "Online BG-management-Ometer" to take over for me, thank you very much!)

Finally, there are some sessions covering "tele-medicine" including using cell phones for better disease managmenet, and a "Tele-Foot program" for assessing diabetic foot health from a group in Warsaw, Polland.

All-in-all, the topics aren't much different from the DTS Meeting in past years.  One can only hope that the content is significantly updated, and that it all translates to improvements in PWD's lives asap!

{Stay tuned for relevant updates.}

Diabetes Technology Society - Nov 2008 Agenda

Disclaimer: Content created by the Diabetes Mine team. For more details click here.


This content is created for Diabetes Mine, a consumer health blog focused on the diabetes community. The content is not medically reviewed and doesn't adhere to Healthline's editorial guidelines. For more information about Healthline's partnership with Diabetes Mine, please click here.